Skip to content
  • Sunday, 26 July 2026
  • 1:47 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • TWiV 1288: Clinical Update with Dr. Daniel Griffin
Microbiology & Immunology

TWiV 1288: Clinical Update with Dr. Daniel Griffin

Lina Irawan Jul 24, 2026 0

In a recent clinical update, Dr. Daniel Griffin and Vincent Racaniello of This Week in Virology (TWiV) expressed profound bewilderment…

Read More
Microbiology & Immunology

TWiV 1290: Clinical update with Dr. Daniel Griffin

Lina Irawan Jul 23, 2026 0

In his latest weekly clinical update, Dr. Daniel Griffin, alongside Vincent Racaniello, delved into a multifaceted array of critical public…

Read More
Microbiology & Immunology

TWiV 1292: Clinical Update with Dr. Daniel Griffin

Lina Irawan Jul 22, 2026 0

In a recent clinical update, Dr. Daniel Griffin and Vincent Racaniello of This Week in Virology (TWiV) have voiced significant…

Read More
Microbiology & Immunology

TWiV 1284: Clinical update with Dr. Daniel Griffin

Lina Irawan Jul 18, 2026 0

In a recent broadcast of "This Week in Virology" (TWiV), episode 1284, Dr. Daniel Griffin and Vincent Racaniello provided a…

Read More
Microbiology & Immunology

TWiV 1286: Clinical Update with Dr. Daniel Griffin

Lina Irawan Jul 18, 2026 0

The latest installment of "This Week in Virology" (TWiV) podcast, episode 1286, featured a comprehensive clinical update from Dr. Daniel…

Read More
Microbiology & Immunology

TWiV 1288: Clinical Update with Dr. Daniel Griffin Examines Alarming Shifts in Childhood Immunization Schedules Amidst Resurging Public Health Threats

Lina Irawan Jul 17, 2026 0

In a recent clinical update on the influential "This Week in Virology" (TWiV) podcast, Dr. Daniel Griffin, alongside host Vincent…

Read More
Microbiology & Immunology

TWiV 1290: Clinical update with Dr. Daniel Griffin

Lina Irawan Jul 16, 2026 0

In a comprehensive clinical update delivered on This Week in Virology (TWiV) episode 1290, Dr. Daniel Griffin provided an in-depth…

Read More
Microbiology & Immunology

TWiV 1292: Clinical update with Dr. Daniel Griffin

Lina Irawan Jul 15, 2026 0

In a stark assessment of the current state of American public health, Dr. Daniel Griffin, a prominent infectious disease clinician,…

Read More
Microbiology & Immunology

TWiV 1284: Clinical update with Dr. Daniel Griffin

Lina Irawan Jul 11, 2026 0

The year 2025 has dawned with a renewed focus on public health challenges, as experts convene to dissect emerging infectious…

Read More
Microbiology & Immunology

TWiV 1286: Clinical update with Dr. Daniel Griffin

Lina Irawan Jul 10, 2026 0

In a recent episode of "This Week in Virology" (TWiV), Dr. Daniel Griffin and host Vincent Racaniello expressed significant concern…

Read More

Posts pagination

1 2 … 9
Marshall University Researchers Uncover Gut Exosomes as Key Players in Age-Related Inflammation and Chronic DiseaseA Sweeping Genetic Analysis Challenges the Single Ancestral Population Theory of Human OriginsResearch Team Uncovers Breakthrough Evidence of Heart Muscle Regeneration in Patients with Artificial HeartsRestoration of Amygdala Neural Balance Reverses Anxiety and Social Deficits in Breakthrough Study
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ